Holdings of VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS · Original filing · Compare with another fund · Report an error
- Net assets
- 36.9B $ including 36.3B $ in equities, 98.4 %
- Positions
- 88 in 10 countries
- Top ten
- 40.7 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 3,582,833 | 3.3B $ | 9.08 % |
| 2 | Merck & Co Inc | 18,279,775 | 2B $ | 5.41 % |
| 3 | AstraZeneca PLC | 9,897,175 | 1.9B $ | 5.09 % |
| 4 | UnitedHealth Group Inc | 3,895,307 | 1.4B $ | 3.92 % |
| 5 | Johnson & Johnson | 5,527,324 | 1.3B $ | 3.45 % |
| 6 | Edwards Lifesciences Corp | 14,158,652 | 1.2B $ | 3.21 % |
| 7 | GSK PLC | 44,002,585 | 1.2B $ | 3.13 % |
| 8 | Intuitive Surgical Inc | 2,186,666 | 1B $ | 2.71 % |
| 9 | Boston Scientific Corp | 15,070,438 | 868.2M $ | 2.36 % |
| 10 | Danaher Corp | 4,836,473 | 865.5M $ | 2.35 % |
| 11 | CVS Health Corp | 9,756,578 | 812.6M $ | 2.20 % |
| 12 | Argenx SE | 1,036,146 | 812.6M $ | 2.20 % |
| 13 | Abbott Laboratories | 8,842,005 | 802.8M $ | 2.18 % |
| 14 | Vertex Pharmaceuticals Inc | 1,801,919 | 770.1M $ | 2.09 % |
| 15 | Cencora Inc | 2,484,451 | 765.2M $ | 2.08 % |
| 16 | Elevance Health Inc | 1,858,361 | 699.5M $ | 1.90 % |
| 17 | Regeneron Pharmaceuticals, Inc. | 931,886 | 658.9M $ | 1.79 % |
| 18 | UCB SA | 2,355,442 | 641.4M $ | 1.74 % |
| 19 | Novartis AG | 4,043,167 | 597.5M $ | 1.62 % |
| 20 | HCA Healthcare Inc | 1,203,410 | 522.8M $ | 1.42 % |
| 21 | Alnylam Pharmaceuticals Inc | 1,670,679 | 517.1M $ | 1.40 % |
| 22 | AbbVie Inc | 2,356,112 | 497.9M $ | 1.35 % |
| 23 | Biogen Inc | 2,526,097 | 478.1M $ | 1.30 % |
| 24 | United Therapeutics Corp | 822,896 | 470.2M $ | 1.28 % |
| 25 | Galderma Group AG | 2,228,631 | 467.6M $ | 1.27 % |
| 26 | Chugai Pharmaceutical Co Ltd | 8,606,142 | 459M $ | 1.25 % |
| 27 | Roche Holding AG | 1,122,465 | 457.4M $ | 1.24 % |
| 28 | Otsuka Holdings Co Ltd | 6,207,200 | 452.4M $ | 1.23 % |
| 29 | Cardinal Health, Inc. | 2,317,298 | 447M $ | 1.21 % |
| 30 | Agilent Technologies Inc | 3,824,222 | 441.9M $ | 1.20 % |
| 31 | Shionogi & Co Ltd | 20,439,649 | 412.9M $ | 1.12 % |
| 32 | Dexcom Inc | 6,365,180 | 379M $ | 1.03 % |
| 33 | Daiichi Sankyo Co Ltd | 22,675,166 | 368.3M $ | 1.00 % |
| 34 | Thermo Fisher Scientific Inc | 745,695 | 357.2M $ | 0.97 % |
| 35 | Genmab A/S | 1,345,944 | 356.4M $ | 0.97 % |
| 36 | Medtronic PLC | 4,228,128 | 342.4M $ | 0.93 % |
| 37 | Stryker Corp | 970,510 | 305.8M $ | 0.83 % |
| 38 | Ionis Pharmaceuticals Inc | 3,803,181 | 284.3M $ | 0.77 % |
| 39 | Revolution Medicines Inc | 1,838,404 | 265M $ | 0.72 % |
| 40 | Ascendis Pharma A/S | 1,049,942 | 240.8M $ | 0.65 % |
| 41 | STERIS PLC | 1,092,821 | 237M $ | 0.64 % |
| 42 | Incyte Corp | 2,365,620 | 225.4M $ | 0.61 % |
| 43 | QIAGEN NV | 6,514,443 | 225.3M $ | 0.61 % |
| 44 | Cytokinetics Inc | 3,482,614 | 222.8M $ | 0.60 % |
| 45 | Bristol-Myers Squibb Co | 3,661,639 | 221.9M $ | 0.60 % |
| 46 | Eisai Co Ltd | 7,339,417 | 219.7M $ | 0.60 % |
| 47 | Madrigal Pharmaceuticals Inc | 408,918 | 211.6M $ | 0.57 % |
| 48 | ICON PLC | 1,538,110 | 182M $ | 0.49 % |
| 49 | Novo Nordisk A/S | 4,131,421 | 175.7M $ | 0.48 % |
| 50 | CG oncology Inc | 2,589,248 | 172.8M $ | 0.47 % |
| 51 | HeartFlow Inc | 5,663,321 | 168.5M $ | 0.46 % |
| 52 | Avantor Inc | 20,480,758 | 165.9M $ | 0.45 % |
| 53 | Scholar Rock Holding Corp | 3,466,533 | 161.6M $ | 0.44 % |
| 54 | Encompass Health Corp | 1,600,016 | 160M $ | 0.43 % |
| 55 | Vaxcyte Inc | 2,667,349 | 152.7M $ | 0.41 % |
| 56 | Xenon Pharmaceuticals Inc | 2,676,154 | 150M $ | 0.41 % |
| 57 | Kymera Therapeutics Inc | 1,796,469 | 145.6M $ | 0.40 % |
| 58 | Alignment Healthcare Inc | 6,287,140 | 141.7M $ | 0.38 % |
| 59 | Celldex Therapeutics Inc | 4,279,485 | 140.7M $ | 0.38 % |
| 60 | Protagonist Therapeutics Inc | 1,380,445 | 136.6M $ | 0.37 % |
| 61 | Crinetics Pharmaceuticals Inc | 3,494,255 | 135.5M $ | 0.37 % |
| 62 | PTC Therapeutics Inc | 2,038,232 | 132.6M $ | 0.36 % |
| 63 | Acadia Healthcare Co Inc | 5,021,479 | 130M $ | 0.35 % |
| 64 | Option Care Health Inc | 6,323,420 | 128.6M $ | 0.35 % |
| 65 | Apogee Therapeutics Inc | 1,490,737 | 123.6M $ | 0.34 % |
| 66 | Structure Therapeutics Inc | 2,909,218 | 120.6M $ | 0.33 % |
| 67 | Immunocore Holdings PLC | 4,246,274 | 118.5M $ | 0.32 % |
| 68 | Inspire Medical Systems Inc | 2,093,826 | 117.5M $ | 0.32 % |
| 69 | Dianthus Therapeutics Inc | 1,244,555 | 109.3M $ | 0.30 % |
| 70 | GenFleet Therapeutics Shanghai Inc | 18,491,938 | 102.9M $ | 0.28 % |
| 71 | Bio-Techne Corp | 1,825,455 | 101M $ | 0.27 % |
| 72 | Duality Biotherapeutics Inc | 2,771,377 | 98.9M $ | 0.27 % |
| 73 | Newamsterdam Pharma Co NV | 3,425,823 | 97.8M $ | 0.27 % |
| 74 | Natera Inc | 470,036 | 96.9M $ | 0.26 % |
| 75 | Moderna Inc | 1,995,366 | 91.7M $ | 0.25 % |
| 76 | M3, Inc. | 9,451,653 | 91M $ | 0.25 % |
| 77 | Arcus Biosciences Inc | 3,445,827 | 87.9M $ | 0.24 % |
| 78 | Nuvalent Inc | 873,258 | 87.6M $ | 0.24 % |
| 79 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 9,939,973 | 82.9M $ | 0.22 % |
| 80 | Zai Lab Ltd | 36,431,700 | 78.2M $ | 0.21 % |
| 81 | Centene Corp | 1,363,754 | 73.2M $ | 0.20 % |
| 82 | Bridgebio Pharma Inc | 982,977 | 69.9M $ | 0.19 % |
| 83 | Immunome Inc | 2,776,580 | 63.7M $ | 0.17 % |
| 84 | Stoke Therapeutics Inc | 1,652,492 | 54.1M $ | 0.15 % |
| 85 | Kailera Therapeutics Inc | 2,127,264 | 53.2M $ | 0.14 % |
| 86 | Mineralys Therapeutics Inc | 1,858,489 | 49.5M $ | 0.13 % |
| 87 | Aktis Oncology Inc | 2,023,644 | 37.9M $ | 0.10 % |
| 88 | Shandong Weigao Group Medical Polymer Co Ltd | 77,092,000 | 34M $ | 0.09 % |
Sector breakdown
- Health care 76.9 %
- Unattributed 23.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 75.4 %
- GBP 8.4 %
- JPY 5.5 %
- CHF 4.2 %
- EUR 4.0 %
- DKK 1.5 %
- HKD 1.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 74.2 %
- United Kingdom 8.4 %
- Japan 5.5 %
- Switzerland 4.2 %
- Belgium 4.0 %
- Denmark 1.5 %
- Hong Kong SAR China 1.1 %
- Ireland 0.5 %
- Canada 0.4 %
- Netherlands 0.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 65 | 26.9B $ | 74.17 % |
| 2 | United Kingdom | 2 | 3B $ | 8.36 % |
| 3 | Japan | 6 | 2B $ | 5.52 % |
| 4 | Switzerland | 3 | 1.5B $ | 4.20 % |
| 5 | Belgium | 2 | 1.5B $ | 4.01 % |
| 6 | Denmark | 2 | 532.1M $ | 1.47 % |
| 7 | Hong Kong SAR China | 5 | 396.8M $ | 1.09 % |
| 8 | Ireland | 1 | 182M $ | 0.50 % |
| 9 | Canada | 1 | 150M $ | 0.41 % |
| 10 | Netherlands | 1 | 97.8M $ | 0.27 % |
Cite this page
Titelia. "Holdings of VANGUARD HEALTH CARE FUND". https://titelia.com/en/funds/S000002922